Overview

hCG Priming in Women With Low Ovarian Reserve

Status:
Recruiting

Trial end date:
2022-12-31

Target enrollment:

Participant gender:

Summary

The aim of this trial is to examine the possible effects of hCG administration for eight weeks prior to IVF/ICSI in women with low ovarian reserve. Primary outcome is the proportion of the antral follicle count that reach the pre-ovulatory stage.

Phase:

Phase 4

Details

Lead Sponsor:

Rigshospitalet, Denmark

Treatments:

Chorionic Gonadotropin